Depression Clinical Trial
Official title:
Testing a Scalable Model of Care to Improve Patients Access to Mental Health Services After Traumatic Injury
The purpose of this study to learn about patients' experience with the Trauma Resilience and Recovery program (TRRP) and/or the enhanced care group.
Status | Recruiting |
Enrollment | 350 |
Est. completion date | August 31, 2025 |
Est. primary completion date | August 31, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 16 Years and older |
Eligibility | Inclusion Criteria: - English- or Spanish-speaking patients = 16 years old who are admitted to George Washington University hospital's trauma center and screen positive on the Injured Trauma Survivors Screen (which indicates risk for development of posttraumatic stress disorder and/or depression) will be included. Exclusion Criteria: - Patients who have a Glasgow Coma Scale score under 13 at hospital admission, moderate to severe cognitive impairment (as measured by the Montreal Cognitive Assessment), active psychosis, or injury that prevents verbal communication (e.g., serious head or spinal cord injury) or is self-inflicted will be excluded. Patients with positive substance use screens via GWU's SBIRT protocol (~7% of the patient population) will be assessed by the clinical team with reference to severity and recency of substance use problems. We have found at MUSC that a high percentage of patients with SBIRT- positive screens are nevertheless good candidates for TRRP (>85%), but patients with serious, active substance abuse problems are likely not good candidates for TRRP and therefore will be excluded and referred to a substance use treatment center. |
Country | Name | City | State |
---|---|---|---|
United States | George Washington University Hospital | Washington | Virginia |
Lead Sponsor | Collaborator |
---|---|
Medical University of South Carolina | Agency for Healthcare Research and Quality (AHRQ), George Washington University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from Baseline PTSD Checklist for DSM-5 8- item (PCL8-5) at 3-,6-, and 12-month | The PTSD Checklist for DSM-5 (Weathers et al., 2013) is a self-report measure that assesses the extent to which participants are bothered by the DSM-5 PTSD symptoms. Each symptom is rated on a scale of 0 (not at all) to 4 (extremely). Total scores are obtained by summing the scores of all items. The 8-item adaptation includes assessment of intrusive thoughts, avoidance of external reminders, negative expectations of self/ world, easily startled, emotional cue reactivity, avoidance of thoughts/emotions, loss of interest, and difficulty concentrating. The PCL8-5 has strong psychometric properties and clinical utility data similar to that of the long version. | Baseline, 3-, 6-, and 12- months post-baseline | |
Secondary | Demographics | Patients will provide standard demographic information, such as race/ethnicity; sex; gender identity; immigration, insurance, marital, and socioeconomic status; language; educational attainment; and occupation | Baseline | |
Secondary | Injured Trauma Survivor Screen (ITSS) | Injured Trauma Survivor Screen (ITSS) is a 9-item measure used to assess risk for development of posttraumatic stress symptoms following injury. Items are rated yes=1 and no=0. If the sum of questions 1, 2, 3, 5, and 6 is equal to or greater than 2, the screen is positive for PTSD risk. If the sum of questions 3, 4, 7, 8, and 9 is equal or greater than 2, the screen is positive for depression risk. | Baseline | |
Secondary | Electronic Medical Record Data (EMR) | Data will be collected at baseline via the electronic medical record including patients' length of stay; injury severity scores; number of emergency department visits; and opioid, anti-anxiety and anti-depression medications prescribed. | Baseline | |
Secondary | The Kessler 6 (K6) | The Kessler 6 (K6) is a screening scale for nonspecific distress to discriminate cases of severe mental illness. Items are rated on a 5-point Likert scale (0-4). Total scores range from 0-24 and are calculated as the sum of all item ratings, with a total score = 5 indicating moderate levels of distress and scores = 13 indicating severe mental illness. This measure has been shown to have strong psychometric properties. | Baseline, 3-, 6-, and 12- months post-baseline | |
Secondary | Patient Health Questionnaire-9 (PHQ-9) | The Patient Health Questionniare-9 (PHQ-9) assesses the presence and frequency of 9 core depressive symptoms. Items are rated on a 4-point Likert scale (0-3). Total scores range from 0-27 and are calculated as the sum of all item ratings, with a total score of = 10 indicating clinical significance. | 3-, 6-, and 12-months post- baseline assessment | |
Secondary | PROMIS Emotional and Instrumental Support | The PROMIS Emotion and Instrumental Support measure assesses perceived feelings of being cared for and valued as a person; having confidant relationships and availability of assistance with material, cognitive, or task performance.
Calculate a summed score across all items. All item responses scored on a scale of 1-5 where Never = 1, Always = 5 3. Score of a 50 is the average for US population, SD of 10 |
Baseline, 3-, 6-, and 12- months post-baseline | |
Secondary | PROMIS Self-Efficacy | The 8-item PROMIS Self-Efficacy scale is a measure of confidence in one's ability to deal effectively with a variety of stressful situations.
Calculate a summed score access all items. All item responses scored on a scale of 1-5 where Never=1, Always = 5 Score of a 50 is the average for US population, SD of 10. |
3-, 6-, and 12-months post- baseline assessment | |
Secondary | PROMIS Global Health | The 10-item PROMIS Global Health questionnaire measures one's overall evaluation of one's physical and mental health. | 3, 6, and 12-months post- baseline assessment | |
Secondary | PROMIS Pain Intensity and Interference Scale | The PROMIS Pain Intensity and Interference scale assesses patients' pain and the extent to which it affects enjoyment of various activities in the past 7 days.
Calculate a summed score access all items. All item responses scored on a scale of 1-5 where Never=1, Always = 5 Score of a 50 is the average for US population, SD of 10. |
3-, 6-, and 12-months post- baseline assessment | |
Secondary | PROMIS Sleep Disturbance | The 4-item PROMIS Sleep Disturbance scale assesses perceptions of sleep quality, sleep depth, and restoration associated with sleep.
Calculate a summed score access all items. All item responses scored on a scale of 1-5. Score of a 50 is the average for US population, SD of 10. |
3, 6, and 12-months post- baseline assessment | |
Secondary | National Health Interview Survey Barriers to Care | This protocol includes 5 interviewer-administered questions from the National Health Interview Survey (NHIS) Barriers to Care designed to assess when medical care was last sought, usual place of care, frequency of getting medical care and reasons for not getting medical care. | Baseline, 3-, 6-, and 12- months post-baseline | |
Secondary | National Health Interview Survey Healthcare Utilization | This protocol includes interviewer-administered questions from the National Health Interview Survey (NHIS) Healthcare Utilization designed to assess when medical care was last sought, usual place of care, frequency of getting medical care and reasons for not getting medical care. | Baseline and 12- months post-baseline | |
Secondary | NHIS Mental Health Care Module | 6 items is designed to assess when mental health care was last sough, usual place of care, frequency of getting mental health care and reasons for not getting mental health care. | Baseline, 3-,6-, and 12-month post baseline | |
Secondary | NHIS Job Status | Consistent with Zatzick and colleagues (2008) we will ask patients about post-injury occupational status. | Baseline, 3-,6-,and 12-month post baseline | |
Secondary | CMH SDOH items | The Centers for Medicare & Medicaid Services (CMS) Center for Medicare and Medicaid Innovation (CMMI) made the Accountable Health Communities (AHC) Health-Related Social Needs (HRSN) Screening Tool to use in the AHC Model.1 The test is to see if systematically finding and dealing with the health-related social needs of Medicare and Medicaid beneficiaries has any effect on their total health care costs and makes their health outcomes better.
The Tool can help providers find out patients' needs in these 5 core domains that community services can help with: Housing instability, food insecurity, transportation problems, Utility help needs and interpersonal safety. |
Baseline, 3-,6-,12-month post baseline | |
Secondary | The California Health Interview Survey (CHIS) question | The California Health Interview Survey (CHIS) question allows a binary measurement of perceived prejudice, stereotyping, and discrimination in clinical encounters and experience. | Baseline, 3-, 6-, and 12- months post-baseline | |
Secondary | Stigma Scale for Receiving Psychological Help | The Stigma Scale for Receiving Psychological Help assesses individuals' perceptions of how stigmatizing it is to receive psychological treatment. The SSRPH consists of 5 questions rated on a 4-point Likert scale.
Total Score Instructions: Total score of the 5 items. No Items are reverse scored. |
3-month post- baseline assessment | |
Secondary | Discrimination in Medical Settings | The 7-item Discrimination in Medical Settings will measure perceived discrimination. | 3-month post baseline | |
Secondary | Collective Efficacy (Neighborhood Environment) | The Neighborhood Environment Scale measures perceived neighborhood context and provides an estimate of cumulative exposure to adversity in childhood. | 3-months post-baseline | |
Secondary | National Adverse Childhood Experiences Questions | The six-item standard measure from the U.S. Department of Agriculture Economic Research Service is a validated, well-established measure of the availability, accessibility, and affordability of nutritionally adequate food. | 3-months post-baseline | |
Secondary | NIDA Quick Screen (items 2-4); alcohol, tobacco, prescription and illicit drug use | The NIDA Quick Screen is a validated instrument designed to assist providers in screening adults for substance use. The screen simply inquires whether a participant has used drugs (mood-altering, illegal, or prescription for nonmedical reasons), alcohol, or tobacco products within the past year and how often these substances have been used. | 3-, 6-, and 12-months post- baseline assessment | |
Secondary | AUDIT-C | The Alcohol Use Disorders Identification Test (AUDIT-C) is an alcohol screen that can help identify patients who are hazardous drinkers or have active alcohol use disorders (including alcohol abuse or dependence). | 3-,6-,12-month post baseline | |
Secondary | Acceptance of Treatment Referral and Initiation of Treatment | Patients will be asked whether they considered seeking assistance for mental health needs and whether they actually sought help. These questions will be based on semi-structured interviews administered via our needs assessment that were adapted from epidemiologic interviews conducted by our team in the aftermath of the September 11, 2001 terrorist attacks and recent natural disasters. Follow-up questions will inquire about whether patients sought help from family members, friends, chaplains, mental health professionals, or other health care professionals. | 3-, 6-, and 12-months post- baseline assessment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Recruiting |
NCT04977232 -
Adjunctive Game Intervention for Anhedonia in MDD Patients
|
N/A | |
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Completed |
NCT04476446 -
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
|
Phase 3 | |
Recruiting |
NCT02783430 -
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT04598165 -
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A |